Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review

Tyler S. Saunders; Danni A. Gadd; Tara L. Spires-Jones; Declan King; Craig Ritchie; Graciela Muniz-Terrera

doi:10.1111/ejn.15656

Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review

Tyler S. Saunders, Danni A. Gadd, Tara L. Spires-Jones, Declan King, Craig Ritchie, Graciela Muniz-Terrera

Research output: Contribution to journal › Review article › peer-review

Original language	English
Journal	European Journal of Neuroscience
Early online date	12 May 2022
DOIs	https://doi.org/10.1111/ejn.15656
Publication status	E-pub ahead of print - 12 May 2022

Keywords / Materials (for Non-textual outputs)

Alzheimer disease
biomarkers
cerebrospinal fluid
cognition
cognitive aging
dementia

Access to Document

10.1111/ejn.15656

Associations between cerebrospinal fluid markers_July 2022Final published version, 58.8 MBLicence: Creative Commons: Attribution (CC-BY)

Cite this

@article{337a456361d645ffbec61ea1855f8ef7,

title = "Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review",

keywords = "Alzheimer disease, biomarkers, cerebrospinal fluid, cognition, cognitive aging, dementia",

author = "Saunders, {Tyler S.} and Gadd, {Danni A.} and Spires-Jones, {Tara L.} and Declan King and Craig Ritchie and Graciela Muniz-Terrera",

note = "Funding Information: The authors would like to thank Marshall Dozier at The University of Edinburgh and the following authors for providing additional data and clarification for papers included in the current review: Professor Ales Bartos and colleagues, Dr Isabelle Bos and colleagues, Professor Sabina Capellari, Professor Piero Parchi and colleagues, Professor Serge Gauthier, Dr Hua Zhang, and colleagues, Dr Cristina Sanfilippo and colleagues, Dr Alexander Santillo and colleagues, Dr Eugeen Vanmechelen and Dr Henrietta Wellington, colleagues and the following funders: Wolfson Foundation, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, Frimurarstiftelsen, Alzheimerfonden, Hj{\"a}rnfonden, the Agneta PrytzFolke and G{\"o}sta Folke Foundation, the Torsten S{\"o}derberg Foundation, NIHR UCL/UCLH Biomedical Research Center and the NIHR Queen Square Dementia Biomedical Research Unit. We would also like to thank Professor Paul Worley and colleagues. Graphical abstract created with Biorender.com. TS and DAG are supported by funding from the University of Edinburgh Translational Neuroscience programme (108890/Z/15/Z). TSJ receives grant funding from the UK Dementia Research Institute, which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK; the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement no 681181; and two collaborating companies, neither of which had any influence over the current paper. CR is funded by the Innovative Medicines Initiative 115736 (EPAD). Publisher Copyright: {\textcopyright} 2022 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.",

year = "2022",

month = may,

day = "12",

doi = "10.1111/ejn.15656",

language = "English",

journal = "European Journal of Neuroscience",

issn = "0953-816X",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review

AU - Saunders, Tyler S.

AU - Gadd, Danni A.

AU - Spires-Jones, Tara L.

AU - King, Declan

AU - Ritchie, Craig

AU - Muniz-Terrera, Graciela

N1 - Funding Information: The authors would like to thank Marshall Dozier at The University of Edinburgh and the following authors for providing additional data and clarification for papers included in the current review: Professor Ales Bartos and colleagues, Dr Isabelle Bos and colleagues, Professor Sabina Capellari, Professor Piero Parchi and colleagues, Professor Serge Gauthier, Dr Hua Zhang, and colleagues, Dr Cristina Sanfilippo and colleagues, Dr Alexander Santillo and colleagues, Dr Eugeen Vanmechelen and Dr Henrietta Wellington, colleagues and the following funders: Wolfson Foundation, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, Frimurarstiftelsen, Alzheimerfonden, Hjärnfonden, the Agneta PrytzFolke and Gösta Folke Foundation, the Torsten Söderberg Foundation, NIHR UCL/UCLH Biomedical Research Center and the NIHR Queen Square Dementia Biomedical Research Unit. We would also like to thank Professor Paul Worley and colleagues. Graphical abstract created with Biorender.com. TS and DAG are supported by funding from the University of Edinburgh Translational Neuroscience programme (108890/Z/15/Z). TSJ receives grant funding from the UK Dementia Research Institute, which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK; the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement no 681181; and two collaborating companies, neither of which had any influence over the current paper. CR is funded by the Innovative Medicines Initiative 115736 (EPAD). Publisher Copyright: © 2022 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

PY - 2022/5/12

Y1 - 2022/5/12

KW - Alzheimer disease

KW - biomarkers

KW - cerebrospinal fluid

KW - cognition

KW - cognitive aging

KW - dementia

U2 - 10.1111/ejn.15656

DO - 10.1111/ejn.15656

M3 - Review article

SN - 0953-816X

JO - European Journal of Neuroscience

JF - European Journal of Neuroscience

ER -